9/3/2009

The FDA has approved Shire's Intuniv, an extended-release ADHD drug for children ages 6 to 17. The British company said the drug, the first selective alpha-2A receptor agonist for ADHD, is expected to be available at U.S. pharmacies in November.

Full Story:
Reuters

Related Summaries